EGFR and neoplasm: The mitogen-activated protein kinase (MAPK)/ERK pathway, a key regulator of tumor proliferation, is initiated when receptor tyrosine kinases (RTKs), such as epidermal growth factor receptor (EGFR) or fibroblast growth factor receptor (FGFR), activate RAS GTPases.